Hemorrhage risk of cerebral dural arteriovenous fistulas following Gamma Knife radiosurgery in a multicenter international consortium.

Gamma Knife arteriovenous complication dural embolization fistula grading hemorrhage outcome radiation scale stereotactic radiosurgery surgery vascular disorders

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
15 Mar 2019
Historique:
received: 31 07 2018
accepted: 12 12 2018
pubmed: 16 3 2019
medline: 16 3 2019
entrez: 16 3 2019
Statut: epublish

Résumé

The authors performed a study to evaluate the hemorrhagic rates of cerebral dural arteriovenous fistulas (dAVFs) and the risk factors of hemorrhage following Gamma Knife radiosurgery (GKRS). Data from a cohort of patients undergoing GKRS for cerebral dAVFs were compiled from the International Radiosurgery Research Foundation. The annual posttreatment hemorrhage rate was calculated as the number of hemorrhages divided by the patient-years at risk. Risk factors for dAVF hemorrhage prior to GKRS and during the latency period after radiosurgery were evaluated in a multivariate analysis. A total of 147 patients with dAVFs were treated with GKRS. Thirty-six patients (24.5%) presented with hemorrhage. dAVFs that had any cortical venous drainage (CVD) (OR = 3.8, p = 0.003) or convexity or torcula location (OR = 3.3, p = 0.017) were more likely to present with hemorrhage in multivariate analysis. Half of the patients had prior treatment (49.7%). Post-GRKS hemorrhage occurred in 4 patients, with an overall annual risk of 0.84% during the latency period. The annual risks of post-GKRS hemorrhage for Borden type 2-3 dAVFs and Borden type 2-3 hemorrhagic dAVFs were 1.45% and 0.93%, respectively. No hemorrhage occurred after radiological confirmation of obliteration. Independent predictors of hemorrhage following GKRS included nonhemorrhagic neural deficit presentation (HR = 21.6, p = 0.027) and increasing number of past endovascular treatments (HR = 1.81, p = 0.036). Patients have similar rates of hemorrhage before and after radiosurgery until obliteration is achieved. dAVFs that have any CVD or are located in the convexity or torcula were more likely to present with hemorrhage. Patients presenting with nonhemorrhagic neural deficits and a history of endovascular treatments had higher risks of post-GKRS hemorrhage.

Identifiants

pubmed: 30875690
doi: 10.3171/2018.12.JNS182208
pii: 2018.12.JNS182208
pmc: PMC6745287
mid: NIHMS1023971
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1209-1217

Subventions

Organisme : NIGMS NIH HHS
ID : U54 GM104942
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002736
Pays : United States

Auteurs

Robert M Starke (RM)

1Department of Neurological Surgery, University of Miami, Florida.

David J McCarthy (DJ)

1Department of Neurological Surgery, University of Miami, Florida.

Ching-Jen Chen (CJ)

2Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Hideyuki Kano (H)

3Department of Neurological Surgery, University of Pittsburgh.

Brendan J McShane (BJ)

4Department of Neurological Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.

John Lee (J)

4Department of Neurological Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.

Mohana Rao Patibandla (MR)

2Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

David Mathieu (D)

5Department of Neurological Surgery, University of Sherbrooke, Quebec, Canada.

Lucas T Vasas (LT)

6Department of Neurological Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.

Anthony M Kaufmann (AM)

6Department of Neurological Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.

Wei Gang Wang (WG)

7Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.

Inga S Grills (IS)

7Department of Radiation Oncology, Beaumont Health System, Royal Oak, Michigan.

Christopher P Cifarelli (CP)

Departments of8Neurological Surgery and.

Gabriella Paisan (G)

2Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

John Vargo (J)

9Radiation Oncology, West Virginia University, Morgantown, West Virginia.

Tomas Chytka (T)

10Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic.

Ladislava Janouskova (L)

10Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic.

Caleb E Feliciano (CE)

11Department of Neurological Surgery, University of Puerto Rico, San Juan, Puerto Rico; and.

Nanthiya Sujijantarat (N)

12Department of Neurological Surgery, Yale University School of Medicine, New Haven, Connecticut.

Charles Matouk (C)

12Department of Neurological Surgery, Yale University School of Medicine, New Haven, Connecticut.

Veronica Chiang (V)

12Department of Neurological Surgery, Yale University School of Medicine, New Haven, Connecticut.

Judith Hess (J)

12Department of Neurological Surgery, Yale University School of Medicine, New Haven, Connecticut.

Rafael Rodriguez-Mercado (R)

11Department of Neurological Surgery, University of Puerto Rico, San Juan, Puerto Rico; and.

Daniel A Tonetti (DA)

3Department of Neurological Surgery, University of Pittsburgh.

L Dade Lunsford (LD)

3Department of Neurological Surgery, University of Pittsburgh.

Jason P Sheehan (JP)

2Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia.

Classifications MeSH